Autolus Therapeutics (AUTL) Free Cash Flow: 2017-2025
Historic Free Cash Flow for Autolus Therapeutics (AUTL) over the last 6 years, with Sep 2025 value amounting to -$72.3 million.
- Autolus Therapeutics' Free Cash Flow rose 16.24% to -$72.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$285.2 million, marking a year-over-year decrease of 57.77%. This contributed to the annual value of -$228.3 million for FY2024, which is 45.84% down from last year.
- Per Autolus Therapeutics' latest filing, its Free Cash Flow stood at -$72.3 million for Q3 2025, which was up 9.68% from -$80.1 million recorded in Q2 2025.
- Autolus Therapeutics' Free Cash Flow's 5-year high stood at -$633,000 during Q4 2022, with a 5-year trough of -$86.3 million in Q3 2024.
- For the 3-year period, Autolus Therapeutics' Free Cash Flow averaged around -$50.6 million, with its median value being -$49.0 million (2024).
- Its Free Cash Flow has fluctuated over the past 5 years, first surged by 93.09% in 2022, then crashed by 5,662.95% in 2024.
- Quarterly analysis of 5 years shows Autolus Therapeutics' Free Cash Flow stood at -$9.2 million in 2021, then soared by 93.09% to -$633,000 in 2022, then slumped by 133.33% to -$1.5 million in 2023, then tumbled by 3,220.65% to -$49.0 million in 2024, then grew by 16.24% to -$72.3 million in 2025.
- Its Free Cash Flow stands at -$72.3 million for Q3 2025, versus -$80.1 million for Q2 2025 and -$83.8 million for Q1 2025.